UK<p><a href="https://www.europesays.com/uk/52461/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/uk/52461/</span><span class="invisible"></span></a> Genetic medicine can leave people with rare mutations behind. But there’s new hope <a href="https://pubeurope.com/tags/APTopNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>APTopNews</span></a> <a href="https://pubeurope.com/tags/BirthDefects" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BirthDefects</span></a> <a href="https://pubeurope.com/tags/Business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Business</span></a> <a href="https://pubeurope.com/tags/Cancer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Cancer</span></a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://pubeurope.com/tags/CysticFibrosis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CysticFibrosis</span></a> <a href="https://pubeurope.com/tags/GarryCutting" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GarryCutting</span></a> <a href="https://pubeurope.com/tags/GeneTherapy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GeneTherapy</span></a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Genetics</span></a> <a href="https://pubeurope.com/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Health</span></a> <a href="https://pubeurope.com/tags/Medication" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Medication</span></a> <a href="https://pubeurope.com/tags/PAStateWire" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PAStateWire</span></a> <a href="https://pubeurope.com/tags/philanthropy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>philanthropy</span></a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Science</span></a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedKingdom</span></a></p>
Recent searches
No recent searches
Search options
Only available when logged in.
zirk.us is one of the many independent Mastodon servers you can use to participate in the fediverse.
Literature, philosophy, film, music, culture, politics, history, architecture: join the circus of the arts and humanities! For readers, writers, academics or anyone wanting to follow the conversation.
Administered by:
Server stats:
730active users
zirk.us: About · Profiles directory · Privacy policy
Mastodon: About · Get the app · Keyboard shortcuts · View source code · v4.3.7
#clinicaltrials
11 posts · 6 participants · 0 posts today
Bytes Europe<p>Novotech CEO On Flexible Trial Solutions Amid Tariff, Geopolitical Tensions <a href="https://www.byteseu.com/956200/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">byteseu.com/956200/</span><span class="invisible"></span></a> <a href="https://pubeurope.com/tags/AsiaPacific" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AsiaPacific</span></a> <a href="https://pubeurope.com/tags/CSuiteSpeaks" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CSuiteSpeaks</span></a> <a href="https://pubeurope.com/tags/China" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>China</span></a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://pubeurope.com/tags/cro" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>cro</span></a> <a href="https://pubeurope.com/tags/Geopolitics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Geopolitics</span></a> <a href="https://pubeurope.com/tags/Interviews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Interviews</span></a> <a href="https://pubeurope.com/tags/tariffs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tariffs</span></a></p>
ASX Mkt. Sensitive<p>Atomo Diagnostics ( <a href="https://mastodon-grafa.social/tags/AT1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AT1</span></a> ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Thu 24 Apr at 15:46 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>live</span></a> <br><a href="https://grafa.com/asset/atomo-diagnostics-ltd-633-at1.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=at1.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/atomo-diagnost</span><span class="invisible">ics-ltd-633-at1.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=at1.asx</span></a></p>
ASX Mkt. Sensitive<p>Cynata Therapeutics ( <a href="https://mastodon-grafa.social/tags/CYP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CYP</span></a> ) has released " March 2025 Quarterly Activity Report and Appendix 4C " on Thu 24 Apr at 13:12 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <br><a href="https://grafa.com/asset/cynata-therapeutics-ltd-1443-cyp.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cyp.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/cynata-therape</span><span class="invisible">utics-ltd-1443-cyp.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cyp.asx</span></a></p>
ASX Mkt. Sensitive<p>Cleo Diagnostics ( <a href="https://mastodon-grafa.social/tags/COV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COV</span></a> ) has released " CLEO Receives A$845k Research and Development Tax Incentive " on Thu 24 Apr at 11:15 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <br><a href="https://grafa.com/asset/cleo-diagnostics-ltd-25800-cov.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cov.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/cleo-diagnosti</span><span class="invisible">cs-ltd-25800-cov.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cov.asx</span></a></p>
ASX Mkt. Sensitive<p>Biotron ( <a href="https://mastodon-grafa.social/tags/BIT" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BIT</span></a> ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Thu 24 Apr at 09:07 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/Strategy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Strategy</span></a> <br><a href="https://grafa.com/asset/biotron-ltd-850-bit.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=bit.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/biotron-ltd-85</span><span class="invisible">0-bit.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=bit.asx</span></a></p>
ASX Mkt. Sensitive<p>PYC Therapeutics ( <a href="https://mastodon-grafa.social/tags/PYC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PYC</span></a> ) has released " Quarterly Activities/Appendix 4C Cash Flow Report " on Thu 24 Apr at 08:48 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <br><a href="https://grafa.com/asset/pyc-therapeutics-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/pyc-therapeuti</span><span class="invisible">cs-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx</span></a></p>
ASX Mkt. Sensitive<p>Imricor Medical Systems ( <a href="https://mastodon-grafa.social/tags/IMR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IMR</span></a> ) has released " Imricor Q1 CY25 Quarterly Activities Report and Appendix 4C " on Wed 23 Apr at 10:19 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <br><a href="https://grafa.com/asset/imricor-medical-systems-inc-2502-imr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imr.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/imricor-medica</span><span class="invisible">l-systems-inc-2502-imr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imr.asx</span></a></p>
ASX Mkt. Sensitive<p>Orthocell ( <a href="https://mastodon-grafa.social/tags/OCC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>OCC</span></a> ) has released " First US Distributors Signed for Remplirs US$1.6B market " on Wed 23 Apr at 09:41 AEST <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/India" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>India</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <br><a href="https://grafa.com/asset/orthocell-ltd-177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/orthocell-ltd-</span><span class="invisible">177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx</span></a></p>
ASX Mkt. Sensitive<p>Race Oncology ( <a href="https://mastodon-grafa.social/tags/RAC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RAC</span></a> ) has released " March 2025 Quarterly Activity Report and Appendix 4C " on Wed 23 Apr at 08:41 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>News</span></a> <br><a href="https://grafa.com/asset/race-oncology-ltd-3890-rac.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=rac.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/race-oncology-</span><span class="invisible">ltd-3890-rac.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=rac.asx</span></a></p>
UK<p><a href="https://www.europesays.com/uk/33633/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/uk/33633/</span><span class="invisible"></span></a> FDA Authorizes First Digital Therapeutic for Migraine <a href="https://pubeurope.com/tags/adherence" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>adherence</span></a> <a href="https://pubeurope.com/tags/AdherenceToMedicationIssuesForPatients" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AdherenceToMedicationIssuesForPatients</span></a> <a href="https://pubeurope.com/tags/ClinicalResearch" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalResearch</span></a> <a href="https://pubeurope.com/tags/ClinicalStudies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalStudies</span></a> <a href="https://pubeurope.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://pubeurope.com/tags/compliance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>compliance</span></a> <a href="https://pubeurope.com/tags/ComputedTomography" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ComputedTomography</span></a> <a href="https://pubeurope.com/tags/CT" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CT</span></a> <a href="https://pubeurope.com/tags/CtScan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CtScan</span></a> <a href="https://pubeurope.com/tags/DrugCompliance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DrugCompliance</span></a> <a href="https://pubeurope.com/tags/grant" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>grant</span></a> <a href="https://pubeurope.com/tags/Health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Health</span></a> <a href="https://pubeurope.com/tags/Medication" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Medication</span></a> <a href="https://pubeurope.com/tags/Migraine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Migraine</span></a>;MigraineHeadache <a href="https://pubeurope.com/tags/PreClinicalTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PreClinicalTrial</span></a> <a href="https://pubeurope.com/tags/TreatmentAdherence" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TreatmentAdherence</span></a> <a href="https://pubeurope.com/tags/U" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>U</span></a>.S.FoodAndDrugAdministration;UnitedStatesFoodAndDrugAdministration;FDA;FoodAndDrugAdministration(FDA);FoodAndDrugAdministration <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedKingdom</span></a></p>
Dining & Cooking<p>Leading Nutrition Scientist Departs N.I.H., Citing Censorship <a href="https://www.diningandcooking.com/2021174/leading-nutrition-scientist-departs-n-i-h-citing-censorship/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">diningandcooking.com/2021174/l</span><span class="invisible">eading-nutrition-scientist-departs-n-i-h-citing-censorship/</span></a> <a href="https://vive.im/tags/Censorship" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Censorship</span></a> <a href="https://vive.im/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://vive.im/tags/DietAndNutrition" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DietAndNutrition</span></a> <a href="https://vive.im/tags/food" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>food</span></a> <a href="https://vive.im/tags/GovernmentEmployees" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GovernmentEmployees</span></a> <a href="https://vive.im/tags/NationalInstitutesOfHealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NationalInstitutesOfHealth</span></a> <a href="https://vive.im/tags/nutrition" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>nutrition</span></a> <a href="https://vive.im/tags/ProcessedAndUltraprocessedFoods" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ProcessedAndUltraprocessedFoods</span></a> <a href="https://vive.im/tags/Research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Research</span></a> <a href="https://vive.im/tags/UnitedStatesPoliticsAndGovernment" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStatesPoliticsAndGovernment</span></a></p>
ASX News in English<p>InhaleRx appoints iNGENū CRO for Phase 1 clinical trial of IRX-616a - published 17 Apr 2025 <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/ASX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ASX</span></a> <a href="https://mastodon-grafa.social/tags/Tech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Tech</span></a> <a href="https://mastodon-grafa.social/tags/BioTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BioTech</span></a> <br><a href="https://grafa.com/news/health-inhalerx-appoints-ingen--cro-for-phase-1-clinical-trial-of-irx-616a-424512?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=424512" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/news/health-inhalerx</span><span class="invisible">-appoints-ingen--cro-for-phase-1-clinical-trial-of-irx-616a-424512?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=424512</span></a></p>
ASX Mkt. Sensitive<p>Clarity Pharmaceuticals ( <a href="https://mastodon-grafa.social/tags/CU6" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CU6</span></a> ) has released " Clarity signs commercial-scale copper-64 Supply Agreement " on Thu 17 Apr at 09:55 AEST <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>News</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <a href="https://mastodon-grafa.social/tags/Strategy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Strategy</span></a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>live</span></a> <br><a href="https://grafa.com/asset/clarity-pharmaceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/clarity-pharma</span><span class="invisible">ceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx</span></a></p>
ASX Mkt. Sensitive<p>Clarity Pharmaceuticals ( <a href="https://mastodon-grafa.social/tags/CU6" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CU6</span></a> ) has released " $11.1 million RDTI and refocus on high-priority programs " on Thu 17 Apr at 09:53 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>News</span></a> <br><a href="https://grafa.com/asset/clarity-pharmaceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/clarity-pharma</span><span class="invisible">ceuticals-ltd-6504-cu6.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cu6.asx</span></a></p>
ASX Mkt. Sensitive<p>Imricor Medical Systems ( <a href="https://mastodon-grafa.social/tags/IMR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IMR</span></a> ) has released " CE Mark Approval for Advantage-MR under EU's MDR " on Thu 17 Apr at 08:53 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <br><a href="https://grafa.com/asset/imricor-medical-systems-inc-2502-imr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imr.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/imricor-medica</span><span class="invisible">l-systems-inc-2502-imr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imr.asx</span></a></p>
ASX Mkt. Sensitive<p>Neuroscientific Biopharmaceuticals ( <a href="https://mastodon-grafa.social/tags/NSB" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NSB</span></a> ) has released " NeuroScientific to Acquire Leading Stem Cell Technology " on Wed 16 Apr at 09:11 AEST <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/trading" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>trading</span></a> <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <br><a href="https://grafa.com/asset/neuroscientific-biopharmaceuticals-ltd-168-nsb.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nsb.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/neuroscientifi</span><span class="invisible">c-biopharmaceuticals-ltd-168-nsb.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nsb.asx</span></a></p>
ASX Mkt. Sensitive<p>Archer Materials ( <a href="https://mastodon-grafa.social/tags/AXE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AXE</span></a> ) has released " Quarterly Activity Report & Appendix 4C " on Wed 16 Apr at 08:20 AEST <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <br><a href="https://grafa.com/asset/archer-exploration-ltd-5699-axe.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=axe.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/archer-explora</span><span class="invisible">tion-ltd-5699-axe.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=axe.asx</span></a></p>
ASX Mkt. Sensitive<p>Nyrada ( <a href="https://mastodon-grafa.social/tags/NYR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NYR</span></a> ) has released " Quarterly Activities Report and Appendix 4C " on Tue 15 Apr at 08:23 AEST <a href="https://mastodon-grafa.social/tags/today" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>today</span></a> <a href="https://mastodon-grafa.social/tags/tax" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tax</span></a> <a href="https://mastodon-grafa.social/tags/government" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>government</span></a> <a href="https://mastodon-grafa.social/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <br><a href="https://grafa.com/asset/nyrada-inc-3430-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/nyrada-inc-343</span><span class="invisible">0-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx</span></a></p>
Bích-Mây Nguyễn :verified:<p>"Thousands of grants, including many at public universities and on topics as politically benign as Alzheimer’s, have been caught in what critics say is an unprecedented slowdown of the American research system that is threatening to upend universities and halt progress toward medical innovations, treatments and cures."</p><p> <a href="https://www.nbcnews.com/health/health-news/one-countrys-leading-alzheimers-projects-jeopardy-rcna199788" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">nbcnews.com/health/health-news</span><span class="invisible">/one-countrys-leading-alzheimers-projects-jeopardy-rcna199788</span></a></p><p><a href="https://med-mastodon.com/tags/healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>healthcare</span></a> <a href="https://med-mastodon.com/tags/NIH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NIH</span></a> <a href="https://med-mastodon.com/tags/HHS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HHS</span></a> <a href="https://med-mastodon.com/tags/science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>science</span></a> <a href="https://med-mastodon.com/tags/research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>research</span></a> <a href="https://med-mastodon.com/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ClinicalTrials</span></a> <a href="https://med-mastodon.com/tags/grants" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>grants</span></a> <a href="https://med-mastodon.com/tags/funding" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>funding</span></a> <a href="https://med-mastodon.com/tags/universities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>universities</span></a> <a href="https://med-mastodon.com/tags/DOGE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DOGE</span></a> <a href="https://med-mastodon.com/tags/USpol" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USpol</span></a></p>
ExploreLive feeds
Mastodon is the best way to keep up with what's happening.
Follow anyone across the fediverse and see it all in chronological order. No algorithms, ads, or clickbait in sight.
Create accountLoginDrag & drop to upload